Skip to main content
Log in

Giant cell arteritis increases outpatient costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2014 US dollars

Reference

  • Koster MJ, et al. Healthcare Use and Direct Cost of Giant Cell Arteritis: A Population-based Study. The Journal of Rheumatology : May 2017. Available from: URL: http://doi.org/10.3899/jrheum.161516

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giant cell arteritis increases outpatient costs. PharmacoEcon Outcomes News 778, 18 (2017). https://doi.org/10.1007/s40274-017-3995-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3995-7

Navigation